Lite Strategy, Inc. (0JW9.L)
LSE · USD
$1.16 (+0.87%) as of
Key statistics
- EPS (TTM)
- -0.5190
- 52-week range
- 1.1600 – 7.8585
- Beta
- 0.01
- Profit margin
- 0.00%
- Volume
- 67.00
About Lite Strategy, Inc.
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. It is also involved in holding Litecoin tokens as a primary reserve asset. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.
- Headquarters
- San Diego, CA, United States
- Employees
- 5
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.